Literature DB >> 25564701

Effects of oleanolic acid on the insulin signaling pathway in skeletal muscle of streptozotocin-induced diabetic male Sprague-Dawley rats.

Andrew Mukundwa1, Samson Mukaratirwa2, Bubuya Masola1.   

Abstract

BACKGROUND: The pant-derived triterpene oleanolic acid (OA) has been shown to have antidiabetic effects, but its action on the insulin signaling cascade has not been fully elucidated. The aim of the present study was to investigate the effects of OA on aspects of the phosphatidylinositol 3-kinase/Akt insulin signaling cascade in skeletal muscle of streptozotocin-induced type 1 diabetic male Sprague-Dawley rats.
METHODS: Diabetic and non-diabetic rats were treated with insulin (4 IU/kg), OA (80 mg/kg), and the combination of OA + insulin in acute 60-min and sub-chronic 14-day studies. Single and daily doses were administered in the acute and sub-chronic studies, respectively. In acute studies, phosphorylated (p-) Akt and p-glycogen synthase (GS) expression was evaluated. In sub-chronic studies, GS and glycogen phosphorylase (GP) expression and activity were evaluated, as were glycogen levels.
RESULTS: The findings show that OA enhances insulin-stimulated hypoglycemic effects in diabetic rats. In the acute study, OA increased levels of p-Akt and decreased levels of p-GS. In the sub-chronic study, OA increased both GS and GP activity, whereas OA + insulin increased GS and decreased GP activity. Treatment of rats with OA and OA + insulin increased GS expression in the skeletal muscle of diabetic rats and decreased GP expression. Glycogen levels were increased by OA but decreased OA + insulin treatment.
CONCLUSION: Oleanolic acid in synergy with insulin can enhance activation of the insulin signaling pathway. Furthermore, the present study provides evidence of OA activation of insulin signaling enzymes independent of insulin.
© 2015 Ruijin Hospital, Shanghai Jiaotong University School of Medicine and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  1型糖尿病; Rattus muscle; insulin signaling enzymes; oleanolic acid; type 1 diabetes; 大鼠肌肉; 胰岛素信号酶; 齐墩果酸

Mesh:

Substances:

Year:  2015        PMID: 25564701     DOI: 10.1111/1753-0407.12260

Source DB:  PubMed          Journal:  J Diabetes        ISSN: 1753-0407            Impact factor:   4.006


  9 in total

1.  Effect of oleanolic acid on small intestine morphology and enzymes of glutamine metabolism in diabetic rats.

Authors:  Murtala Bindawa Isah; Bubuya Masola
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2017-11-01

2.  Oleanolic acid protects against diabetic cardiomyopathy via modulation of the nuclear factor erythroid 2 and insulin signaling pathways.

Authors:  Wei-Fang Li; Peng Wang; Hua Li; Tian-Yi Li; Ming Feng; Su-Fang Chen
Journal:  Exp Ther Med       Date:  2017-05-31       Impact factor: 2.447

3.  Therapeutic Potential of Pterostilbene and Resveratrol on Biomechanic, Biochemical, and Histological Parameters in Streptozotocin-Induced Diabetic Rats.

Authors:  Bora Tastekin; Aykut Pelit; Sait Polat; Abdullah Tuli; Leman Sencar; Mustafa Muhlis Alparslan; Yusuf Kenan Daglioglu
Journal:  Evid Based Complement Alternat Med       Date:  2018-05-16       Impact factor: 2.629

Review 4.  Oleanolic Acid and Its Derivatives: Biological Activities and Therapeutic Potential in Chronic Diseases.

Authors:  Taiwo Betty Ayeleso; Mashudu Given Matumba; Emmanuel Mukwevho
Journal:  Molecules       Date:  2017-11-13       Impact factor: 4.411

5.  Molecular basis of the anti-hyperglycemic activity of RA-3 in hyperlipidemic and streptozotocin-induced type 2 diabetes in rats.

Authors:  Sihle Ephraim Mabhida; Rabia Johnson; Musawenkosi Ndlovu; Johan Louw; Andrew Opoku; Rebamang Anthony Mosa
Journal:  Diabetol Metab Syndr       Date:  2019-03-29       Impact factor: 3.320

Review 6.  Potential Protective Effect of Oleanolic Acid on the Components of Metabolic Syndrome: A Systematic Review.

Authors:  Ángel Fernández-Aparicio; Jacqueline Schmidt-RioValle; Javier S Perona; María Correa-Rodríguez; Jose M Castellano; Emilio González-Jiménez
Journal:  J Clin Med       Date:  2019-08-23       Impact factor: 4.241

Review 7.  The Use of Bioactive Compounds in Hyperglycemia- and Amyloid Fibrils-Induced Toxicity in Type 2 Diabetes and Alzheimer's Disease.

Authors:  Ancuta-Veronica Lupaescu; Monica Iavorschi; Mihai Covasa
Journal:  Pharmaceutics       Date:  2022-01-20       Impact factor: 6.321

8.  Manipulations of glucose/lipid metabolism and gut microbiota of resistant starch encapsulated Ganoderma lucidum spores in T2DM rats.

Authors:  Yumei Jiang; Na Zhang; Yawen Zhou; Zhongkai Zhou; Yu Bai; Padraig Strappe; Chris Blanchard
Journal:  Food Sci Biotechnol       Date:  2021-04-24       Impact factor: 2.391

9.  A Lanosteryl triterpene from Protorhus longifolia augments insulin signaling in type 1 diabetic rats.

Authors:  Sihle Ephraim Mabhida; Rabia Johnson; Musawenkosi Ndlovu; Nonhlakanipho Felicia Sangweni; Johan Louw; Andrew Opoku; Rebamang Anthony Mosa
Journal:  BMC Complement Altern Med       Date:  2018-10-01       Impact factor: 3.659

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.